المؤلفون: Kemp Bohan PM; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas. phillip.m.kempbohan.mil@mail.mil., Chick RC; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas., O'Shea AE; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas., Vreeland TJ; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas., Hickerson AT; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas., Cindass JL; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas., Ensley DC; Department of Urology, Brooke Army Medical Center, Ft. Sam Houston, Texas., Hale D; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas., Clifton GT; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas., Sohn VY; Department of Surgery, Madigan Army Medical Center, Joint Base Lewis-McChord, Washington., Thompson IM Jr; Department of Urology, UT Health-San Antonio, San Antonio, Texas.; CHRISTUS Santa Rosa Medical Center, San Antonio, Texas., Peoples GE; Cancer Vaccine Development Program, San Antonio, Texas., Liss MA; Department of Urology, UT Health-San Antonio, San Antonio, Texas.

المصدر: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2021 May; Vol. 14 (5), pp. 551-562. Date of Electronic Publication: 2021 Jan 29.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE

مواضيع طبية MeSH: Watchful Waiting*, Prostatic Neoplasms/*therapy , Sirolimus/*adverse effects, Aged ; Disease Progression ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Prostatic Neoplasms/diagnosis ; Quality of Life ; Sirolimus/administration & dosage ; Treatment Outcome